BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 17369093)

  • 21. [Respiratory virus infections and inflammatory cytokines in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease].
    Zhao CL; Huang JW; Zhang L; Zhang QR; Li QM; Zhou M
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Dec; 41(12):942-948. PubMed ID: 30522191
    [No Abstract]   [Full Text] [Related]  

  • 22. [The role of respiratory infection in exacerbation of chronic obstructive pulmonary disease].
    Dacydchenko SV; Bova AA
    Klin Med (Mosk); 2007; 85(5):10-5. PubMed ID: 17665597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap.
    Lau EMT; Roche NA; Reddel HK
    Expert Rev Clin Immunol; 2017 May; 13(5):449-455. PubMed ID: 27977310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease.
    Brightling CE
    Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S214-9. PubMed ID: 24313775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies.
    Watson A; Spalluto CM; McCrae C; Cellura D; Burke H; Cunoosamy D; Freeman A; Hicks A; Hühn M; Ostridge K; Staples KJ; Vaarala O; Wilkinson T
    Am J Respir Crit Care Med; 2020 Jan; 201(1):83-94. PubMed ID: 31461630
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevalence and risk factors of respiratory viral infection in acute exacerbation of chronic obstructive pulmonary disease].
    Du XB; Ma X; Gao Y; Wen LF; Li J; Wang ZZ; Liu S
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Apr; 40(4):263-266. PubMed ID: 28395404
    [No Abstract]   [Full Text] [Related]  

  • 28. Targeting the IL-33/IL-13 Axis for Respiratory Viral Infections.
    Donovan C; Bourke JE; Vlahos R
    Trends Pharmacol Sci; 2016 Apr; 37(4):252-261. PubMed ID: 26833119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of viral respiratory infections in the pathogenesis and exacerbation of asthma.
    Cohen L; Castro M
    Semin Respir Infect; 2003 Mar; 18(1):3-8. PubMed ID: 12652448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review.
    Zheng XY; Xu YJ; Guan WJ; Lin LF
    Arch Virol; 2018 Apr; 163(4):845-853. PubMed ID: 29327237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Impact of respiratory viruses on the course of chronic obstructive pulmonary disease: towards optimizing treatment].
    Kalyuzhin OV; Chelenkova IN; Ponezheva ZB
    Ter Arkh; 2015; 87(3):98-104. PubMed ID: 26027249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of viral respiratory infections in asthma and asthma exacerbations.
    Busse WW; Lemanske RF; Gern JE
    Lancet; 2010 Sep; 376(9743):826-34. PubMed ID: 20816549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory Viral Infections in Chronic Lung Diseases.
    Britto CJ; Brady V; Lee S; Dela Cruz CS
    Clin Chest Med; 2017 Mar; 38(1):87-96. PubMed ID: 28159164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation.
    Guo-Parke H; Linden D; Weldon S; Kidney JC; Taggart CC
    Front Immunol; 2020; 11():1205. PubMed ID: 32655557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral infections in patients with chronic obstructive pulmonary disease.
    Varkey JB; Varkey B
    Curr Opin Pulm Med; 2008 Mar; 14(2):89-94. PubMed ID: 18303415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the mechanisms of viral induced asthma: new therapeutic directions.
    Hansbro NG; Horvat JC; Wark PA; Hansbro PM
    Pharmacol Ther; 2008 Mar; 117(3):313-53. PubMed ID: 18234348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and Risk Factors of Respiratory Viral Infections in Exacerbations of Chronic Obstructive Pulmonary Disease.
    Kwak HJ; Park DW; Kim JE; Park MK; Koo GW; Park TS; Moon JY; Kim TH; Sohn JW; Yoon HJ; Shin DH; Kim SH
    Tohoku J Exp Med; 2016 Oct; 240(2):131-139. PubMed ID: 27725531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease.
    Ko FW; Chan PK; Chan RWY; Chan KP; Ip A; Kwok A; Ngai JC; Ng SS; On CT; Hui DS
    Respir Res; 2019 Sep; 20(1):210. PubMed ID: 31519188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between respiratory viruses and exacerbation of COPD: a case-control study.
    Hosseini SS; Ghasemian E; Jamaati H; Tabaraie B; Amini Z; Cox K
    Infect Dis (Lond); 2015 Aug; 47(8):523-9. PubMed ID: 25800059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.
    Buhl R; Farmer SG
    Proc Am Thorac Soc; 2004; 1(2):136-42. PubMed ID: 16113426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.